Case 9.14

2014 ◽  
pp. 446-447
Author(s):  
Christine U. Lee ◽  
James F. Glockner
Keyword(s):  
United States ◽  
Lung Cancer ◽  
Mortality Rate ◽  
Colorectal Carcinoma ◽  
Elderly Patients ◽  
The United States ◽  
Incidence Rates ◽  
Adenomatous Polyps ◽  
Colorectal Cancers ◽  
Cancer Death

60-year-old man with anemia and progressive fatigue Coronal SSFP (Figure 9.14.1) and postgadolinium 3D SPGR (Figure 9.14.2) images show a focal nonobstructive mass in the cecum, with mural thickening and hyperenchancement. Cecal adenocarcinoma Colorectal carcinoma is the second leading cause of cancer death (after lung cancer) in the United States. Incidence rates have remained relatively stable over the past 30 years while the mortality rate has decreased, particularly in women. Most colorectal cancers arise from adenomatous polyps, which are common in middle-aged and elderly patients. Screening and autopsy studies describe an incidence of more than 30%, although less than 1% of these polyps become malignant....

Breast Cancer Clinical Practice Guidelines in Oncology

2005 ◽  
Vol 3 (3) ◽  
pp. 238 ◽  
Keyword(s):  
Breast Cancer ◽  
United States ◽  
Lung Cancer ◽  
Breast Cancer Mortality ◽  
The United States ◽  
Cancer Death ◽  
Cancer Society ◽  
The Past ◽  
Recent Version ◽  
Common Malignancy

The American Cancer Society estimates that approximately 217,440 new cases of breast cancer will have been diagnosed in the United States in the year 2004 and approximately 40,580 patients will die of this disease. Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The incidence of breast cancer has increased steadily in the United States over the past few decades, but breast cancer mortality appears to be declining. This suggests a benefit from early detection and more effective treatment. For the most recent version of the guidelines, please visit NCCN.org

Lung Cancer

2014 ◽  
pp. 98-106
Author(s):  
Kim-Son Nguyen ◽  
Joel Neal
Keyword(s):  
United States ◽  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
The United States ◽  
Small Cell ◽  
American Cancer Society ◽  
Cancer Death ◽  
Small Cell Lung ◽  
Cancer Society

Cancer of the lung is a group of heterogeneous malignant disorders composed of small cell lung cancer (13%), non-small cell lung cancer (NSCLC) (86%), and rare thoracic malignancies such as mesothelioma and carcinoid tumors. In 2008 the American Cancer Society estimated that 215,020 people in the United States would develop lung cancer, and 161,840 people would die of their disease. In men the age-adjusted cancer death rate for lung cancer peaked in 1990 at approximately 90 deaths per 100,000 and has since decreased to 70 per 100,000. In women, the incidence reached a plateau in 1990 at 40 per 100,000. These changes are in part due to alterations in smoking patterns, but the overall incidence of lung cancer continues to increase with the aging population. Despite the trend of decreased smoking rates in industrialized countries, lung cancer remains the leading cause of cancer death in both men and women in the United States (American Cancer Society, 2008). Lung cancer is also the leading cause of cancer death worldwide.

scholarly journals Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009

Lung Cancer ◽  
2014 ◽  
Vol 86 (1) ◽  
pp. 22-28 ◽  
Author(s):  
Keisha A. Houston ◽  
S. Jane Henley ◽  
Jun Li ◽  
Mary C. White ◽  
Thomas B. Richards
Keyword(s):  
United States ◽  
Lung Cancer ◽  
Cancer Incidence ◽  
The United States ◽  
Incidence Rates ◽  
Histologic Type ◽  
Lung Cancer Incidence ◽  
Cancer Incidence Rates

End-of-life care for elderly patients with advanced lung cancer in the United States and Ontario.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 6021-6021
Author(s):  
K. Yabroff ◽  
J. Warren ◽  
L. C. Barbera ◽  
K. Bremner ◽  
J. Hoch ◽  
...  
Keyword(s):  
United States ◽  
Lung Cancer ◽  
Elderly Patients ◽  
End Of Life ◽  
End Of Life Care ◽  
The United States ◽  
Advanced Lung Cancer ◽  
Life Care

Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States

Lung Cancer ◽  
2009 ◽  
Vol 63 (2) ◽  
pp. 264-270 ◽  
Author(s):  
Kathleen Lang ◽  
Martin D. Marciniak ◽  
Doug Faries ◽  
Michael Stokes ◽  
Don Buesching ◽  
...  
Keyword(s):  
United States ◽  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
The United States ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Line Chemotherapy

Lung Cancer in Women

2005 ◽  
Vol 23 (14) ◽  
pp. 3212-3218 ◽  
Author(s):  
Jyoti D. Patel
Keyword(s):  
Breast Cancer ◽  
United States ◽  
Lung Cancer ◽  
Genetic Variation ◽  
The United States ◽  
Cancer Death ◽  
Prevention Strategies ◽  
Lung Cancer Patients ◽  
Treatment And Prevention ◽  
Biologic Factors

Lung cancer is the leading cause of cancer death in the United States and is responsible for 20,000 more deaths yearly in US women than breast cancer. Cigarette smoking is the major cause of lung cancer, and unfortunately, approximately 22 million US women smoke. Mounting evidence suggests that there are significant differences in lung cancer between the sexes. There is a difference in the histologic distribution of lung cancer, with glandular differentiation being more common in women. Genetic variation may account for differences in susceptibility, and hormonal and biologic factors may play a role in carcinogenesis. Lung cancer patients have few therapeutic options. A more thorough understanding of the heterogeneity of lung cancer across populations may lead to innovations in treatment and prevention strategies.

The Fifty-Year Decline of Cancer in America

2001 ◽  
Vol 19 (1) ◽  
pp. 239-241 ◽  
Author(s):  
Brad Rodu ◽  
Philip Cole
Keyword(s):  
United States ◽  
Lung Cancer ◽  
Mortality Rate ◽  
Cancer Mortality ◽  
The United States ◽  
Mortality Rates ◽  
Health Statistics ◽  
The Past ◽  
The Impact

PURPOSE: From 1950 to 1990, the overall cancer mortality rate increased steadily in the United States, a trend which ran counter to declining mortality from other major diseases. The purpose of this study was to assess the impact of lung cancer on all-cancer mortality over the past 50 years. METHODS: Data from the National Centers for Health Statistics were used to develop mortality rates for all forms of cancer combined, lung cancer, and other-cancer (all-cancer minus lung cancer) from 1950 to 1998. RESULTS: When lung cancer is excluded, mortality from all other forms of cancer combined declined continuously from 1950 to 1998, dropping 25% during this period. The decline in other-cancer mortality was approximately 0.4% annually from 1950 to 1990 but accelerated to 0.9% per year from 1990 to 1996 and to 2.2% per year from 1996 to 1998. CONCLUSION: The long-term decline is likely due primarily to improvements in medical care, including screening, diagnosis, and treatment.

Sign in / Sign up

Export Citation Format

Share Document